Similarly, we found that doxorubicin treatment ex vivo significantly increased levels of ICAM-1 in the cytoplasm and membrane of tumor cells (p=0.023), which was prevented by MLN120B (p=0.008) (Fig. 3D and 3E). Here, ICAM1 is linked to neoplasm.